Ethereum will discuss new methods to hide transactions before execution on August 19, aiming to increase the difficulty for predatory bot operations. The focus of the discussion will be on the public mempool, where pending orders can be observed before they enter the blockchain, making them susceptible to automated traders. This exploitation is common in sandwich attacks, where bots buy the same asset upon detecting a pending swap transaction, pushing the price in a direction unfavorable to the user, and then immediately sell after the order is executed. Although this issue has lessened compared to previous peaks, it has not disappeared. The meeting will analyze several proposals aimed at concealing transaction details until their position in the block is determined, reducing the information advantage of bots and block builders. One of the proposals under analysis is LUCID, registered as EIP-8184, which envisions builders committing to sealed transactions with chargeable receipts and encrypted payloads without prior knowledge of the specific transaction operations. However, this model could lead to the decryption keys being held by the sender or an external key issuer, and currently, there are no rules in the Ethereum protocol to prove or penalize key withholding, premature disclosure, or abuse by issuers. Additionally, this proposal needs to be integrated into the broader roadmap of the network; LUCID aims to expand the inclusion list pipeline related to FOCIL, also known as EIP-7805, which empowers multiple validators to identify transactions that builders must include.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.

Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.















Long-end U.S. Treasury yields surged to multi-year highs, pressuring technology, semiconductor, storage, and optical communication stocks and driving a clear cooling in market risk appetite. At the same time, Anthropic’s revenue came in below some bullish expectations, prompting investors to reassess the AI growth narrative; Unitree Robotics officially listed on the STAR Market, extending momentum in robotics and embodied AI; while SpaceX and other commercial space names showed relative resilience. Investors are now focused on tonight’s Federal Reserve minutes for clearer signals on the policy path and broader market sentiment.














Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.